FITC conjugate of caspase inhibitor DEVD-FMK that binds to activated caspase-3 in apoptic cells.
CAT No: HB00016
Fitc-DEVD-FMK is a synthetic peptide inhibitor that combines a fluorochrome-labeled tetrapeptide sequence with a fluoromethyl ketone (FMK) reactive group. As a cell-permeable, irreversible inhibitor of caspase-3 and related DEVDase activities, it serves as a powerful tool in the study of apoptosis and programmed cell death. The FITC (fluorescein isothiocyanate) tag enables direct visualization and tracking within biological samples, making this compound especially valuable for live-cell imaging and flow cytometry applications. Its design allows for the selective targeting and covalent modification of active caspases, providing researchers with both functional inhibition and fluorescent detection capabilities in a single molecule.
Apoptosis research: Fitc-DEVD-FMK is widely employed in apoptosis research to detect and inhibit caspase-3-like protease activity in living cells. The DEVD peptide sequence serves as a specific recognition motif for caspase-3 and related enzymes, while the FMK moiety forms a covalent bond with the active site cysteine, resulting in irreversible enzyme inactivation. This dual functionality enables researchers to both block apoptotic signaling pathways and visualize caspase activation events, facilitating detailed mechanistic studies of cell death processes.
Cell-based assays: In cell biology laboratories, the compound is routinely used in fluorescence-based assays to monitor caspase activation in real time. The FITC label allows for direct detection of inhibitor-bound caspases by flow cytometry, fluorescence microscopy, or plate readers, providing quantitative and spatial information about apoptotic cell populations. This capability is particularly useful for high-throughput screening of apoptosis-inducing agents or for assessing the efficacy of candidate compounds in modulating programmed cell death.
Protease profiling: Fitc-DEVD-FMK enables selective profiling of caspase activity within complex biological samples. By covalently binding to active caspase-3, it allows for the enrichment and subsequent identification of active protease populations using fluorescence-based techniques. This application is valuable in dissecting the temporal and spatial dynamics of caspase activation during various cellular events, as well as in the validation of novel caspase substrates or interacting partners.
Mechanistic studies: The compound supports detailed investigations into the molecular mechanisms underlying caspase-mediated signaling pathways. By providing both inhibition and fluorescent labeling of active caspases, it allows researchers to dissect the sequence of events leading to cellular apoptosis, map caspase activation cascades, and study the cross-talk between different proteolytic pathways. Such mechanistic insights are crucial for understanding the regulation of cell fate decisions in physiological and pathological contexts.
Live-cell imaging: Fitc-DEVD-FMK is particularly suited for live-cell imaging studies, as its cell-permeable nature and fluorescent tag enable real-time visualization of caspase activity within intact cells. Researchers can monitor the onset and progression of apoptosis at the single-cell level, track the subcellular localization of active caspases, and analyze dynamic changes in response to various stimuli. This approach provides a powerful means to correlate biochemical events with morphological changes during cell death, offering a comprehensive view of apoptotic processes in living systems.
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.